New paradigms in cell death in human diabetic nephropathy

Maria-Dolores Sanchez-Niño1, Alberto Benito-Martin, Alberto Ortiz

  • 1Department of Nefrologia, IIS Fundacion Jimenez Diaz, Madrid, Spain.

Kidney International
|August 13, 2010
PubMed

Insights

Diabetic nephropathy involves cell death, with novel molecules like TRAIL and BASP1 identified. Further research is needed to understand endoplasmic reticulum stress and therapeutic interventions for kidney disease.

Area of Science:

  • Nephrology
  • Molecular Biology
  • Genetics

Background:

  • Cell death contributes to progressive renal cell loss in diabetic nephropathy.
  • High glucose environments in diabetes accelerate kidney damage.
  • Understanding cell death mechanisms is crucial for treating diabetic nephropathy.

Purpose of the Study:

  • To identify novel cell death molecules and proapoptotic proteins in human diabetic nephropathy.
  • To investigate the role of endoplasmic reticulum stress in diabetic kidney disease.
  • To explore potential therapeutic targets for apoptosis in diabetic nephropathy.

Main Methods:

  • Unbiased gene expression profiling to identify novel cell death molecules.
  • Functional genomic screens for apoptosis mediators.
  • Cell culture studies to assess functional relevance in high glucose conditions.
  • Genome-wide expression profiling integrated with functional screens.

Main Results:

  • Expression of TNF-related apoptosis-inducing ligand (TRAIL), osteoprotegerin, Fas, and CD74 were induced in human diabetic nephropathy.
  • Brain acid-soluble protein 1 (BASP1) was identified as a novel proapoptotic candidate.
  • Evidence suggests induction of endoplasmic reticulum stress response in diabetic nephropathy.
  • Cell culture studies confirmed the functional relevance of observed molecules in high glucose.

Conclusions:

  • Novel cell death molecules and proapoptotic proteins are upregulated in diabetic nephropathy.
  • Endoplasmic reticulum stress is implicated in cell death in diabetic kidney disease, though further functional studies are required.
  • Future research should focus on therapeutic interventions targeting apoptosis pathways in diabetic nephropathy and chronic kidney disease.

Related Concept Videos

Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
Diabetic Neuropathy01:22

Diabetic Neuropathy

DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...